What is the drug of choice for labor induction in a pregnant woman diagnosed with intrauterine fetal death?

Dinoprostone is often considered the drug of choice for labor induction in cases of intrauterine fetal death due to its effective properties in promoting cervical ripening and stimulating uterine contractions. Dinoprostone, a prostaglandin E2, is used to facilitate vaginal delivery in women who require induction due to fetal demise.

The mechanism of action involves softening and effacing the cervix, which can help prepare the uterus for labor. It is particularly favorable in this context because it can be administered both vaginally and intracervically, allowing for a more controlled induction process.

While other options such as oxytocin and misoprostol also induce labor, they are generally utilized in different scenarios or may be less preferred due to variations in efficacy and safety. For instance, misoprostol (a prostaglandin E1 analog) can be effective but isn't the primary choice when cervical ripening is of utmost importance, especially in women with fetal demise. Thus, dinoprostone is favored for its specific properties that align closely with the needs of such clinical situations.